The budget also proposes to extend Medicare solvency and give the federal government more power to negotiate prescription drug prices.| Healthcare Dive
-- Diluted EPS of $2.04; Adjusted Diluted EPS of $2.11 -- -- Increases 2023 Full Year Guidance and Updates 2024 Target -- Increased 2023 full year Adjusted EPS guidance to at least $6.40 driven by...| Investor Relations | Centene Corporation
States began disenrolling ineligible beneficiaries from Medicaid earlier this year in an event the CMS has called the biggest health coverage transition since the first ACA open enrollment.| Healthcare Dive